Journal Watch - Survival

« Back to Most Recent

  1. European Patients Live Longer with Extended HD Treatments

    Compared to standard in-center HD, patients from eight European countries who dialyzed for 6+ hours thrice weekly lived longer. Of 142,460 patients, 1,338 did extended HD. Compared to in-center HD (13.5/100 person-years), crude mortality for extended HD (6.0/100 person-years) was significantly better. Overall, those treated with extended treatments were 73% more likely to have survived.

    Read the abstract » | (added 12/10/2019)

    Tags: Survival, Extended Hours Hemodialysis, Haemodialysis, Era Edta Registry

  2. Frequency vs. Time in HD Survival

    Which matters more for HD--the number of treatments per week, or the length of each treatment? A retrospective registry study from the ANZDATA database looked at survival among 16,944 non-indigenous adult patients in Australia and New Zealand from 2001 to 2015. After controlling for frequency, patients with 5+ hour long treatments had significantly better survival than those whose treatments <5 hours. However, controlling for duration, increasing frequency did not boost survival.

    Read the abstract » | (added 06/13/2019)

    Tags: Anzdata, Session Frequency, Session Duration, Survival, End Stage Kidney Disease

  3. BMI and Survival on PD

    A large study from Korea (N=80,674 PD patients) found that those in the highest group for BMI: just 25.71, had significantly higher all cause mortality.

    Read the abstract » | (added 06/13/2019)

    Tags: Body Mass Index, Survival, Diabetes Mellitus, Peritoneal Dialysis, Mortality

  4. Daily HD Practices in France and Australia/New Zealand

    Registry data from both regions compared all incident patients who dialyzed 5-6 sessions per week—both daytime and nocturnal—with one-to-one matching of French to Australia/New Zealand patients based on age, sex, and dialysis start year. While survival and transplant access were comparable, other intriguing differences appeared.

    Read the abstract » | (added 05/15/2019)

    Tags: Registry Data, Dialysis Interval, Survival, Transplant Acces

  5. Home HD - Significantly Better Survival and Transplant Rate

    A Swedish matched cohort study compared the long-term survival of 152 home HD patients with those doing PD (n=456) or standard in-center HD (n=608). Median survival for home HD was significantly better (18.5 years) than PD (15.0) and in-center HD (11.9). Home HD patients were also significantly more likely to have received a transplant.

    Read the abstract » | (added 03/12/2019)

    Tags: Survival, Home Hemodialysis, Institutional Hemodialysis, Peritoneal Dialysis